Literature DB >> 8692963

Heterodimer formation and activity in the human enzyme galactose-1-phosphate uridylyltransferase.

J P Elsevier1, L Wells, B B Quimby, J L Fridovich-Keil.   

Abstract

One of the fundamental questions concerning expression and function of dimeric enzymes involves the impact of naturally occurring mutations on subunit assembly and heterodimer activity. This question is of particular interest for the human enzyme galactose-l-phosphate uridylyl-transferase (GALT), impairment of which results in the inherited metabolic disorder galactosemia, because many if not most patients studied to date are compound heterozygotes rather than true molecular homozygotes. Furthermore, the broad range of phenotypic severity observed in these patients raises the possibility that allelic combination, not just allelic constitution, may play some role in determining outcome. In the work described herein, we have selected two distinct naturally occurring null mutations of GALT, Q188R and R333W, and asked the questions (i) what are the impacts of these mutations on subunit assembly, and (ii) if heterodimers do form, are they active? To answer these questions, we have established a yeast system for the coexpression of epitope-tagged alleles of human GALT and investigated both the extent of specific GALT subunit interactions and the activity of defined heterodimer pools. We have found that both homodimers and heterodimers do form involving each of the mutant subunits tested and that both heterodimer pools retain substantial enzymatic activity. These results are significant not only in terms of their implications for furthering our understanding of galactosemia and GALT holoenzyme structure-function relationships but also because the system described may serve as a model for similar studies of other complexes composed of multiple subunits.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692963      PMCID: PMC38954          DOI: 10.1073/pnas.93.14.7166

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Sequence of a cDNA encoding human galactose-1-phosphate uridyl transferase.

Authors:  J E Flach; J K Reichardt; L J Elsas
Journal:  Mol Biol Med       Date:  1990-08

2.  Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.

Authors:  R Gentz; C H Chen; C A Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Efficient site-directed in vitro mutagenesis using phagemid vectors.

Authors:  J A McClary; F Witney; J Geisselsoder
Journal:  Biotechniques       Date:  1989-03       Impact factor: 1.993

4.  Galactose 1-phosphate uridylyltransferase of Escherichia coli. II. Further purification and characterization.

Authors:  S Saito; M Ozutsumi; K Kurahashi
Journal:  J Biol Chem       Date:  1967-05-25       Impact factor: 5.157

5.  Purification of normal and inactive galactosemic galactose-1-phosphate uridylyltransferase from human red cells.

Authors:  G L Dale; G Popják
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

6.  The structure of an antigenic determinant in a protein.

Authors:  I A Wilson; H L Niman; R A Houghten; A R Cherenson; M L Connolly; R A Lerner
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

7.  Molecular studies on galactose 1 phosphate uridylyl transferase from normal and mutant subjects. An immunological approach.

Authors:  J Banroques; F Schapira; C Grégori; J C Dreyfus
Journal:  Ann Hum Genet       Date:  1983-07       Impact factor: 1.670

8.  Purification and some properties of galactose 1-phosphate uridylyltransferase from human red cells.

Authors:  V P Williams
Journal:  Arch Biochem Biophys       Date:  1978-11       Impact factor: 4.013

9.  Cloning and characterization of a cDNA encoding human galactose-1-phosphate uridyl transferase.

Authors:  J K Reichardt; P Berg
Journal:  Mol Biol Med       Date:  1988-04

10.  Molecular characterization of two galactosemia mutations: correlation of mutations with highly conserved domains in galactose-1-phosphate uridyl transferase.

Authors:  J K Reichardt; S Packman; S L Woo
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

View more
  14 in total

1.  Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia.

Authors:  L Wells; J L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase.

Authors:  B B Quimby; A Alano; S Almashanu; A M DeSandro; T M Cowan; J L Fridovich-Keil
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Improvement of galactose uptake in Saccharomyces cerevisiae through overexpression of phosphoglucomutase: example of transcript analysis as a tool in inverse metabolic engineering.

Authors:  Christoffer Bro; Steen Knudsen; Birgitte Regenberg; Lisbeth Olsson; Jens Nielsen
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

4.  Studies of the V94M-substituted human UDPgalactose-4-epimerase enzyme associated with generalized epimerase-deficiency galactosaemia.

Authors:  T M Wohlers; J L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

5.  A Drosophila melanogaster model of classic galactosemia.

Authors:  Rebekah F Kushner; Emily L Ryan; Jennifer M I Sefton; Rebecca D Sanders; Patricia Jumbo Lucioni; Kenneth H Moberg; Judith L Fridovich-Keil
Journal:  Dis Model Mech       Date:  2010-06-02       Impact factor: 5.758

6.  Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.

Authors:  Thomas J McCorvie; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2013-04-11

7.  Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia.

Authors:  T M Wohlers; N C Christacos; M T Harreman; J L Fridovich-Keil
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

9.  A yeast model reveals biochemical severity associated with each of three variant alleles of galactose-1P uridylyltransferase segregating in a single family.

Authors:  J S Chhay; K K Openo; J S Eaton; M Gentile; J L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2008-01-22       Impact factor: 4.982

Review 10.  Galactose toxicity in animals.

Authors:  Kent Lai; Louis J Elsas; Klaas J Wierenga
Journal:  IUBMB Life       Date:  2009-11       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.